Short bowel syndrome (SBS) with intestinal failure Program in Pharmaceutical Benefits Scheme (PBS) 012-19100123
Expand allThis document outlines details of PBS-subsidised teduglutide for patients with short bowel syndrome (SBS) with intestinal failure.
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Short bowel syndrome (SBS) with intestinal failure quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial PB275 form |
Written Electronic S100: teduglutide |
No |
OPA |
Must be treated by a:
|
Yes - delayed assessment. No additional free text information to assess. Assess and approve/reject as per usual process. |
|
Continuing PB276 form |
Written Electronic S100: teduglutide |
No |
OPA |
Must be treated by a:
|
Yes - delayed assessment. No additional free text information to assess. Assess and approve/reject as per usual process. |
|
Balance of supply |
Telephone Electronic S100: teduglutide |
No |
OPA |
Must be treated by a:
|
Yes |